Funding for this research was provided by:
Universitätsklinikum Regensburg
Article History
Received: 9 August 2023
Accepted: 20 October 2023
First Online: 6 December 2023
Declarations
:
: Florian Hitzenbichler: Travel grants from Gilead Sciences. Lecture fees from MSD Sharp and Dohme and Pfizer.Bernd Salzberger: Lecture fees from Falk Foundation, consultation fees from Roche. Markus Weber: Research Grant of the Federal Ministry of Education and Research (BMBF).